Skip to main content

Soni Manmeet Singh's Form 4 filing

Reata Pharmaceuticals Inc (RETA) · filed Jun 14, 2023

Accession no.
0001209191-23-037043
Filed
Jun 14, 2023
Trade date
Jun 12-13, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $8.50M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Soni Manmeet SinghCIK 0001569769Officer (COO, CFO and President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 12, 2023Class A common stockSSaleDisposed−4,711$99.62−$469,309.82111,461Direct
Jun 13, 2023Class A common stockMOption exerciseAcquired+25,000$27.32+$683,000136,461Direct
Jun 13, 2023Class A common stockSSaleDisposed−9,326$99.75−$930,268.5127,135Direct
Jun 13, 2023Class A common stockSSaleDisposed−9,157$101.05−$925,314.85117,978Direct
Jun 13, 2023Class A common stockSSaleDisposed−16,163$101.98−$1,648,302.74101,815Direct
Jun 13, 2023Class A common stockSSaleDisposed−3,643$102.73−$374,245.3998,172Direct
Jun 13, 2023Class A common stockSSaleDisposed−25,530$104.09−$2,657,417.772,642Direct
Jun 13, 2023Class A common stockSSaleDisposed−14,016$105.05−$1,472,380.858,626Direct
Jun 13, 2023Class A common stockSSaleDisposed−250$105.55−$26,387.558,376Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 13, 2023Class A common stockMOption exerciseDisposed−25,000$0.00$075,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)